>watch the trailer
compressed to share as well
https://fonds-josefa.org/en/
Pr Jean-Bernard Fourtillan answers questions from Pr Henri Joyeux
A non-profit endowment fund for your health
Professors Jean-Bernard Fourtillan and His friends have decided to unite their efforts in order to announce to the general public, at the same time as to healthcare professionals and to researchers, this essential discovery and the medicinal products (single- or dual-compartment patches), in the process of being prepared, which result therefrom.
They created a non-profit endowment fund, the Josefa Fund, to which were given, in their totality, the intellectual property rights to the medicinal product patents resulting from this discovery.
https://youtu.be/P3t5XsIeSSM { in Parisian French, so enable ENG CC }
Dec 23, 2016
THIS is what (((they))) are criminally charging him for { as it exposes the PHARMAKIA CABAL }
TRANSDERMAL PATCHES delivering
Valentonin (VLT) and 6-Methoxy-Harmalan (6-MH)
will be available for patients in 2017 (4th quarter)